Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pulmonary vasculitis.

R Y Leavitt, A S Fauci

    The American Review of Respiratory Disease
    |July 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Pulmonary vasculitis, including granulomatous conditions like Wegener's, often affects the lungs. Ruling out infections is crucial; effective treatments combine immunosuppressants and corticosteroids, yielding high survival rates.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The management of subglottic stenosis in patients with Wegener's granulomatosis.

    The Laryngoscope·1992
    Same author

    The treatment of Wegener's granulomatosis with glucocorticoids and methotrexate.

    Arthritis and rheumatism·1992
    Same author

    Interferon gamma induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells.

    The Journal of experimental medicine·1992
    Same author

    CD34+ bone marrow cells are infected with HIV in a subset of seropositive individuals.

    Journal of immunology (Baltimore, Md. : 1950)·1992
    Same author

    Lymphokine production by B cells from normal and HIV-infected individuals.

    Annals of the New York Academy of Sciences·1992
    Same author

    Pharmacologic regulation of HIV expression.

    AIDS research and human retroviruses·1992
    Same journal

    Human lung lysozyme: sources and properties.

    The American review of respiratory disease·2015
    Same journal

    "Immotile-cilia" syndrome and ciliary abnormalities induced by infection and injury.

    The American review of respiratory disease·2013
    Same journal

    Adult criteria for obstructive apnea do not identify children with serious obstruction.

    The American review of respiratory disease·1993
    Same journal

    Cell adhesion molecules and the bronchial epithelium.

    The American review of respiratory disease·1993
    Same journal

    Adhesion molecules and cytokine production.

    The American review of respiratory disease·1993
    Same journal

    Molecular mechanisms mediating lymphocyte recirculation, inflammation, and metastasis formation.

    The American review of respiratory disease·1993
    See all related articles

    Area of Science:

    • Pulmonary Medicine
    • Rheumatology
    • Pathology

    Background:

    • Granulomatous vasculitides frequently involve the lungs, encompassing conditions such as Wegener's granulomatosis.
    • Necrotizing sarcoid granulomatosis is a pulmonary vasculitis, distinct from systemic vasculitis.
    • Infectious agents can mimic pulmonary vasculitis, necessitating their exclusion for accurate diagnosis.

    Purpose of the Study:

    • To review the spectrum of pulmonary vasculitis.
    • To highlight diagnostic considerations, particularly differentiating vasculitis from infections.
    • To outline current therapeutic strategies and outcomes for pulmonary vasculitis.

    Main Methods:

    • Literature review of granulomatous vasculitides and pulmonary vasculitis.
    • Discussion of differential diagnoses, focusing on infectious mimics.

    Related Experiment Videos

  • Summary of treatment approaches for various forms of pulmonary vasculitis.
  • Main Results:

    • Pulmonary vasculitis includes Wegener's granulomatosis, allergic angiitis, and polyangiitis overlap syndrome.
    • Pulmonary capillaritis can lead to pulmonary hemorrhage.
    • Hypersensitivity vasculitides require antigen removal and corticosteroid therapy.
    • Systemic vasculitides treated with cyclophosphamide and corticosteroids show a 5-year survival of approximately 90%.

    Conclusions:

    • Accurate diagnosis of pulmonary vasculitis requires excluding infectious etiologies.
    • Treatment strategies vary based on the underlying cause, ranging from antigen removal to immunosuppression.
    • Combination therapy for systemic vasculitis offers a high survival rate, underscoring treatment efficacy.